Zesoxyn Oral Suspension
By Zesoxyn
Rx
200ml Oral Suspension in a Bottle

Composition
Sucralfate(1000mg) + Oxetacaine(20mg)

Manufacturer - Semiotic Pharmaceutical Private Limited
Plot No-325/2273, Sarala Niwas Near Jaydev College, Nahara Kanta, Hansapal Bhubaneswar Khordha Or 752101 India

Expires on or after
July, 2026

liver
Safety Advice - Liver Limited information is available regarding the safety of Zesoxyn Oral Suspension in individuals with liver disease. It is highly recommended to consult with your doctor before using this medication if you have any preexisting liver conditions. Your healthcare provider will be able to assess the potential risks and benefits of using Doucid-S in relation to your liver health, and provide you with personalized guidance on the appropriate dosage and frequency of administration. It is crucial to prioritize your liver health and seek professional medical advice to ensure the safe and effective use of Zesoxyn Oral Suspension.

kidney
Use Zesoxyn Oral Suspension carefully if you have kidney disease. Your doctor may need to adjust the dosage. Consult with your doctor for proper guidance before using Zesoxyn Oral Suspension.

alcohol
It is advised to be cautious when drinking alcohol while taking Zesoxyn Oral Suspension. Consult your doctor for guidance.

driving
When using Zesoxyn Oral Suspension, be cautious as it may cause drowsiness, blurred vision, or dizziness. Avoid driving if experiencing these side effects.

pregnancy
Safety Advice for Pregnancy It is important to note that there is no specific information available about the use of Zesoxyn Oral Suspension during pregnancy. Therefore, it is recommended to consult your doctor before using this medication.

breastfeeding
It is better to consult your doctor before using Zesoxyn Oral Suspension during breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | GASTRO INTESTINAL |
| Action Class | - |
₹225
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024
